Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms.
A J
AJ
Steck
N
N
Murray
D000911:Antibodies, Monoclonal / Q000276:immunology; D000917:Antibody Formation; D000941:Antigens / Q000276:immunology*; D001696:Biomechanical Phenomena; D003711:Demyelinating Diseases / Q000276:immunology* / Q000503:physiopathology; D006651:Histocytochemistry; D006801:Humans; D007120:Immunochemistry; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008232:Lymphoproliferative Disorders / Q000503:physiopathology; D009185:Myelin Proteins / Q000276:immunology* / Q000378:metabolism; D018992:Myelin-Associated Glycoprotein; D009420:Nervous System / Q000378:metabolism; D009422:Nervous System Diseases / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D010956:Plasmapheresis
D000911:Antibodies, Monoclonal; D000941:Antigens; D007166:Immunosuppressive Agents; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein